A glutamine-based single α-helix scaffold to target globular proteins
- PMID: 36400768
- PMCID: PMC9674830
- DOI: 10.1038/s41467-022-34793-6
A glutamine-based single α-helix scaffold to target globular proteins
Abstract
The binding of intrinsically disordered proteins to globular ones can require the folding of motifs into α-helices. These interactions offer opportunities for therapeutic intervention but their modulation with small molecules is challenging because they bury large surfaces. Linear peptides that display the residues that are key for binding can be targeted to globular proteins when they form stable helices, which in most cases requires their chemical modification. Here we present rules to design peptides that fold into single α-helices by instead concatenating glutamine side chain to main chain hydrogen bonds recently discovered in polyglutamine helices. The resulting peptides are uncharged, contain only natural amino acids, and their sequences can be optimized to interact with specific targets. Our results provide design rules to obtain single α-helices for a wide range of applications in protein engineering and drug design.
© 2022. The Author(s).
Conflict of interest statement
M.B. and X.S. are founders of Nuage Therapeutics. M.B. is an employee of Nuage Therapeutics. X.S. is a scientific advisor of Nuage Therapeutics. The remaining authors declare no competing interests.
Figures
References
-
- Fuller JC, Burgoyne NJ, Jackson RM. Predicting druggable binding sites at the protein–protein interface. Drug Discov. Today. 2009;14:155–161. - PubMed
-
- Philippe GJB, Craik DJ, Henriques ST. Converting peptides into drugs targeting intracellular protein-protein interactions. Drug Discov. Today. 2021;26:1521–1531. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
